People · Operator
Named in public records as an officer, director or promoter · active 2019–2020 · Medical Devices
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Bardy Diagnostics, Inc. | — | Medical Devices | Series B | $89.8M | $11.9M | 2019 |
Kevin H. Nelson, III at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Kevin H. Nelson, III on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Garheng H. Kong | 1 | 2 |
| Gust H. Bardy | 1 | 2 |
| Warren H. Watson | 1 | 1 |
| Alan H. Levy | 1 | 1 |
| Mark H. Handfelt | 1 | 1 |
| David H. Tamburri | 1 | 1 |
| Paul H. LaViolette | 1 | 1 |
| Rik H. Vandevenne | 1 | 1 |
| Mark H. Querry | 1 | 1 |
| Ed H. Vertatschitsch | 1 | 1 |
| Patrick H. Wethington | 1 | 1 |
| Jon P. Hunt | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.